Projets novateurs réalisés

In-Flight data analysis at the Fragment Separator FRS at GSI

Artificial intelligence for systematic and efficient production of battery materials

L2M – Mector (A supportive memory solution for dementia patients)

Mector is a user-friendly communication system designed to support seniors with dementia, helping them live independently at home while providing peace of mind to their family caregivers. Dementia often poses significant daily challenges, leaving family members feeling stressed and concerned about their loved one’s safety and well-being, especially when they are alone. Mector addresses these challenges with an easy-to-use smart case attached to a smartphone, facilitating patient communication through daily tasks such as personalized reminders, voice guidance, and alerts for important activities like taking medications, eating regularly, or maintaining daily routines. Additionally, Mector employs advanced technology like AI to track patients’ behaviour patterns and supervise and relay this information to families. It also incorporates smart sensors and location tracking to promptly notify family caregivers if there is a potential safety concern, such as falls, wandering, or missed medications. Through this technology, caregivers can monitor daily activities remotely and receive timely updates, reducing anxiety and helping them feel more confident in caring for their loved ones at home. The partner organization will benefit from providing an innovative, affordable, and practical dementia-care solution that addresses a critical need for families in Canada.

L2M – SEEYA

SEEYA project addresses the growing global epidemic of childhood myopia, a condition that has reached alarming levels due to genetic impacts, urbanization, increased screen time and reduced outdoor activity.

SEEYA advocates a fun way to see, and a new way to play! A series of innovative, engaging, and educational toy sets that promote balanced indoor screen time, outdoor activities, and eye health awareness. By encouraging children to explore the world through different visual effects and perspectives as well as stimulating their creativity from DIY modules, SEEYA therefore to foster healthier vision conditions and habits in an appealing way for younger generations worldwide.

Tracking the microbiome in inflammatory bowel disease with optical imaging

L2M QC Spring 2025 | Concusono: Portable AI-Powered Ultrasound for Concussion Detection

Concussions pose a critical health risk in sports and other high-impact environments, yet timely and accurate diagnosis remains a challenge. Existing tools are expensive, non-portable, and impractical for field use, leading to delayed or missed diagnoses and increased long-term health risks. Concusono is revolutionizing concussion detection with a novel AI-driven portable ultrasound device that provides direct, rapid, and on-the-spot assessment, overcoming the limitations of existing solutions.

Performing Drug Screenings followed by Sequencing on the Droplet Microarray for Precision Oncology

Define the impact of shift work on autoimmunity and autoimmune diseases

Networked Bio-hybrid Systems for Environmental Monitoring

Neutron Detector Development

CoVE SEED (Centres of Vocational Excellence for Sustainable Energy Education)

L2M – Approaches to Novel Anticancer Therapeutics via MRCK Inhibition

MRCK is an enzyme that has shown promise as a target for the development of new drugs to treat several aggressive cancers, including glioblastoma (GBM) and high grade serous ovarian cancer (HGSOC). BDP9066 is a highly potent and selective inhibitor of MRCK reported first in 2018. Despite excellent activity profile, BDP9066 is not a realistic clinical candidate due to it’s rapid metabolism and complicated synthesis, which would limit scale-up capacity from a practical standpoint. In this project, we aim to discover molecules similar to BDP9066 that do not possess the aforementioned detrimental attributes; this will be done through knowledge-based designs of new small molecules, their synthesis, and biochemical/biological evaluation for MRCK inhibition.